Indiana University School of Medicine researcher Jeff Dage’s years of research into biomarkers helped lead to a ...

Agappe Corporate Office COCHIN, KERALA, INDIA, June 20, 2025 /EINPresswire / -- Agappe Diagnostics Ltd is poised to pioneer a transformative c ...

Down Syndrome, caused by an extra copy of chromosome 21, is one of the most common chromosomal disorders, marked by ...

The Food and Drug Administration’s (FDA) approval of the first blood test to aid in the diagnosis of Alzheimer’s disease ...

It is with deep sorrow and profound admiration that the Alzheimer's Drug Discovery Foundation (ADDF) shares the passing of Co ...

David Hyde Pierce hosted the CaringKind Gala for Alzheimer's awareness in New York City, sharing his personal connection to ...

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...

Ixico said it was contracted by Fujirebio Diagnostics Inc, a Tokyo-based biomarker research company, to assist with the development of a new blood-based test for Alzheimer's disease called Lumipulse.

NewAmsterdam Pharma’s push to show a cholesterol drug can prevent Alzheimer’s disease has passed another test. The phase 3 sub-study tracked significant changes in an Alzheimer’s biomarker ...

The U.S. Food and Drug Administration has approved the marketing of a new tool to that can test a person’s blood to diagnose ...